This company has been marked as potentially delisted and may not be actively trading. Vermillion (VRML) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock VRML vs. AWH, MYMD, NAVB, VNRX, ANRO, ADAP, ASRT, YI, CLSD, and AKYAShould you be buying Vermillion stock or one of its competitors? The main competitors of Vermillion include Aspira Women's Health (AWH), MyMD Pharmaceuticals (MYMD), Navidea Biopharmaceuticals (NAVB), VolitionRx (VNRX), Alto Neuroscience (ANRO), Adaptimmune Therapeutics (ADAP), Assertio (ASRT), 111 (YI), Clearside Biomedical (CLSD), and Akoya Biosciences (AKYA). These companies are all part of the "medical" sector. Vermillion vs. Its Competitors Aspira Women's Health MyMD Pharmaceuticals Navidea Biopharmaceuticals VolitionRx Alto Neuroscience Adaptimmune Therapeutics Assertio 111 Clearside Biomedical Akoya Biosciences Vermillion (NASDAQ:VRML) and Aspira Women's Health (NASDAQ:AWH) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability. Which has more risk and volatility, VRML or AWH? Vermillion has a beta of 3.47, meaning that its stock price is 247% more volatile than the S&P 500. Comparatively, Aspira Women's Health has a beta of 2.01, meaning that its stock price is 101% more volatile than the S&P 500. Do analysts prefer VRML or AWH? Aspira Women's Health has a consensus price target of $5.50, suggesting a potential upside of 6,607.32%. Given Aspira Women's Health's stronger consensus rating and higher possible upside, analysts plainly believe Aspira Women's Health is more favorable than Vermillion.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Vermillion 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aspira Women's Health 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Which has higher valuation & earnings, VRML or AWH? Vermillion has higher earnings, but lower revenue than Aspira Women's Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioVermillion$4.54M4.72-$15.24MN/AN/AAspira Women's Health$9.18M0.27-$16.69M-$0.98-0.08 Is VRML or AWH more profitable? Aspira Women's Health has a net margin of -165.07% compared to Vermillion's net margin of -307.31%. Aspira Women's Health's return on equity of 0.00% beat Vermillion's return on equity.Company Net Margins Return on Equity Return on Assets Vermillion-307.31% -155.25% -103.47% Aspira Women's Health -165.07%N/A -267.23% Do institutionals & insiders hold more shares of VRML or AWH? 18.1% of Vermillion shares are held by institutional investors. Comparatively, 12.2% of Aspira Women's Health shares are held by institutional investors. 4.4% of Vermillion shares are held by insiders. Comparatively, 4.3% of Aspira Women's Health shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to VRML or AWH? In the previous week, Vermillion's average media sentiment score of 0.00 equaled Aspira Women's Health'saverage media sentiment score. Company Overall Sentiment Vermillion Neutral Aspira Women's Health Neutral SummaryAspira Women's Health beats Vermillion on 7 of the 13 factors compared between the two stocks. Get Vermillion News Delivered to You Automatically Sign up to receive the latest news and ratings for VRML and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding VRML and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VRML vs. The Competition Export to ExcelMetricVermillionDiagnostic Substances IndustryMedical SectorNASDAQ ExchangeMarket Cap$21.42M$17.96M$5.54B$9.41BDividend YieldN/AN/A3.75%4.03%P/E Ratio-1.29N/A21.0120.09Price / Sales4.7218.41433.8199.01Price / CashN/AN/A36.1658.27Price / Book2.440.018.125.65Net Income-$15.24M-$15.34M$3.25B$257.91M Vermillion Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VRMLVermillionN/A$0.22+22.9%N/A-87.1%$21.42M$4.54M-1.2943Gap UpAWHAspira Women's HealthN/A$0.08-12.5%$5.50+6,607.3%-94.1%$2.44M$9.18M-0.07110High Trading VolumeMYMDMyMD PharmaceuticalsN/A$0.12+2.1%N/A-94.3%$280KN/A0.006Gap DownHigh Trading VolumeNAVBNavidea BiopharmaceuticalsN/A$0.00+50.0%N/A-90.0%$30K$8.13K0.0010VNRXVolitionRx2.1339 of 5 stars$0.70+4.0%$3.50+400.0%+3.3%$72.12M$1.31M-1.9480News CoverageAnalyst ForecastGap UpANROAlto Neuroscience1.9122 of 5 stars$2.43+6.6%$8.50+249.8%-82.1%$65.78MN/A-1.04N/AADAPAdaptimmune Therapeutics1.8158 of 5 stars$0.25+2.9%$1.35+445.0%-78.1%$65.73M$178.03M-0.92490Gap DownASRTAssertio2.111 of 5 stars$0.68+4.2%$2.75+302.0%-59.6%$65.51M$124.96M-2.1420YI1110.2359 of 5 stars$7.53+0.5%N/A-28.9%$65.07M$1.97B-11.772,110CLSDClearside Biomedical2.3687 of 5 stars$0.84+2.5%$4.75+468.9%-50.3%$64.89M$1.66M-2.0430Trending NewsAnalyst DowngradeGap DownAKYAAkoya Biosciences2.35 of 5 stars$1.29-5.1%$2.51+94.3%N/A$64.44M$81.67M-1.3390Positive News Related Companies and Tools Related Companies Aspira Women's Health Competitors MyMD Pharmaceuticals Competitors Navidea Biopharmaceuticals Competitors VolitionRx Competitors Alto Neuroscience Competitors Adaptimmune Therapeutics Competitors Assertio Competitors 111 Competitors Clearside Biomedical Competitors Akoya Biosciences Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VRML) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersUtah’s New Oil FindThe Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...Stansberry Research | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredHedge fund legend humiliates Bitcoin tradersLarry Benedict made $274 million trading on Wall Street… Barron’s ranked his hedge fund in the top 1% world...Brownstone Research | SponsoredFREE BUY ALERT: These 3 tiny AI stocks could surgeWe're living in unprecedented times. Most people think it's too late to get into AI right now … That the...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Vermillion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Vermillion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free VRML Stock Alerts